VERTICAL // PHARMACEUTICAL & AI DRUG DISCOVERY
Handwritten Note Source: + Pharmaceutical
1. Domain Overview & Divergent Outlier Angle
De novo drug design, ligand-protein binding affinity prediction, virtual screening pipelines, and ADMET toxicity modeling.
Divergent thinkers in this vertical possess deep hyper-focus and non-consensus mastery. They reject surface-level trends in favor of underlying mechanisms, physical constraints, and mathematical elegance.
- Primary Persona Affinities: 01.01 Frontier AI Builders, 01.04 Obsessive Polymaths
- Founding Note Origin: Transcribed directly from Founder Field Note Page 5 (
+ Pharmaceutical).
2. Frontier Tech & Systems Intersections
Equivariant diffusion models (DiffDock), cryo-EM structure reconstruction algorithms, and automated microfluidic bio-laboratories.
3. Where to Find Them (Signal Channels)
Biotech Twitter, bioRxiv daily preprints, AI in Biomedicine Discord servers, OpenFold development channels.
4. Tactical Acquisition & Engagement Vector
Share verified benchmarks comparing diffusion-based docking speeds vs. traditional AutoDock Vina; contribute to open-source bio-pipelines.
Rule: Never use corporate outreach or generic marketing templates. Treat them as peer specialists who respect precision and despise patronizing sales copy.
5. Cross-Disciplinary Collisions
Extends 02.05 Chemical & Molecular Informatics and feeds into sovereign health optimization in 02.18 Nutrition & Metabolic Biochemistry.